首页|期刊导航|生物医学研究杂志(英文版)|Dual therapy of rosiglitazone/pioglitazone with glimepiride on diabetic nephropathy in experimentally induced type 2 diabetes rats
生物医学研究杂志(英文版)2011,Vol.25Issue(6):411-417,7.
Dual therapy of rosiglitazone/pioglitazone with glimepiride on diabetic nephropathy in experimentally induced type 2 diabetes rats
Dual therapy of rosiglitazone/pioglitazone with glimepiride on diabetic nephropathy in experimentally induced type 2 diabetes rats
摘要
关键词
type 2 diabetes mellitus/diabetic nephropathy/peroxisome proliferator activated receptors (PPARs)/transforming growth factor-β1 (TGF-β1)/tumor necrosis factor-α (TNF-α)Key words
type 2 diabetes mellitus/diabetic nephropathy/peroxisome proliferator activated receptors (PPARs)/transforming growth factor-β1 (TGF-β1)/tumor necrosis factor-α (TNF-α)引用本文复制引用
Ravi Prakash Rao,Ansima Singh,Arun Kjain,Bhartu Parsharthi Srinivasan..Dual therapy of rosiglitazone/pioglitazone with glimepiride on diabetic nephropathy in experimentally induced type 2 diabetes rats[J].生物医学研究杂志(英文版),2011,25(6):411-417,7.基金项目
Authors are thankful to GNCT,New Delhi,India for financial support and Institute of PathologyICMR,New Delhi,India for histopathological studies.Authors also thank Panacea Biotec Ltd.Baddi,Solan (H.P.),India,for providing the gift samples of the drugs. (H.P.)